E Fund Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $329K | Buy |
9,052
+752
| +9% | +$27.3K | 0.02% | 286 |
|
|
2025
Q1 | $301K | Buy |
8,300
+1,100
| +15% | +$39.8K | 0.01% | 313 |
|
|
2024
Q4 | $303K | Buy |
7,200
+877
| +14% | +$36.9K | 0.02% | 313 |
|
|
2024
Q3 | $351K | Sell |
6,323
-1,339
| -17% | -$74.4K | 0.02% | 235 |
|
|
2024
Q2 | $315K | Sell |
7,662
-915
| -11% | -$37.6K | 0.02% | 224 |
|
|
2024
Q1 | $400K | Sell |
8,577
-3,294
| -28% | -$154K | 0.02% | 221 |
|
|
2023
Q4 | $568K | Buy |
11,871
+2,467
| +26% | +$118K | 0.04% | 134 |
|
|
2023
Q3 | $335K | Buy |
9,404
+711
| +8% | +$25.3K | 0.03% | 198 |
|
|
2023
Q2 | $401K | Sell |
8,693
-1,271
| -13% | -$58.6K | 0.03% | 166 |
|
|
2023
Q1 | $400K | Sell |
9,964
-434
| -4% | -$17.4K | 0.03% | 166 |
|
|
2022
Q4 | $482K | Buy |
10,398
+725
| +7% | +$33.6K | 0.04% | 133 |
|
|
2022
Q3 | $401K | Buy |
9,673
+894
| +10% | +$37.1K | 0.04% | 184 |
|
|
2022
Q2 | $524K | Buy |
8,779
+4,678
| +114% | +$279K | 0.05% | 136 |
|
|
2022
Q1 | $298K | Buy |
+4,101
| New | +$298K | 0.01% | 199 |
|